|
|
|
|
|
|||||||
|
Session 50
Poster Session
Therapeutic Vaccine Studies 4:30-6:30 pm 4E-F |
to view the poster for an abstract.| 312-W. | Control of Viral Load Rebound during Treatment Interruptions in Macaques with AIDS Induced by a Novel Topical DNA Immunization (DermaVir) J. Lisziewicz*1, J. Xu1, J. Trocio1, L. Whitman1, M. G. Lewis2, and F. Lori1 1Res. Inst. for Genetic and Human Therapy, Washington, DC and 2SRI, Frederick, MD
| ||
| 313-W. | Containment of Viral Rebound after Antiretroviral Therapy Suspension in Macaques Chronically Infected with SIV following Vaccination with NYVAC-SIV Recombinant Vaccines E. Tryniszewska*1, 2, M. G. Lewis3, Z. Hel1, J. Nacsa1, W-P. Tsai1, L. Stevceva1, R. W. Parks1, M. Moniuszko1, S. Cairns4, K. A. Smith5, J. Tartaglia6, and G. Franchini1 1NCI, NIH, Bethesda, MD; 2Med. Academy of Bialystok, Poland; 3Southern Res. Inst., Frederick, MD; 4NIAID, NIH, Bethesda, MD; 5Cornell Univ., New York, NY; and 6Aventis-Pasteur, Toronto, ON, Canada
| ||
| 314-W. | Therapeutic Immunization with Remune Alters Kinetics of Viral Rebound after Analytical Therapy Interruption (ATI) R. P. Bucy*1, R. B. Moss2, and M. Gersten3 for the 06A Study Team 1Univ. of Alabama, Birmingham; 2Immune Response Corp., Carlsbad, CA; and 3Agouron Pharmaceuticals, La Jolla, CA
| ||
| 315-W. | Immunogenicity of Remune in Subjects with Established HIV Infection G. Robbins*, M. M. Addo, H. Troung, A. Rathod, K. Habeeb, N. Basgoz, B. Davis, H. Heller, B. Walker, and E. Rosenberg Massachusetts Gen. Hosp. and Partners AIDS Res. Ctr., Boston
| ||
| 316-W. | Induction of HIV-1-Specific Reactivity in CD8+ and CD4+ T Cells from Patients on Combination Antiretroviral Drug Therapy by Dendritic Cells Loaded with HIV-1-Infected Apoptotic Cells X-Q. Zhao1, X. L. Huang1, L. Borowski1, P. Gupta1, Z. Fan1, S. Watkins1, E. Thomas2, and C. Rinaldo Jr.*1 1Univ. of Pittsburgh, PA and 2Immunex Corp., Seattle, WA
| ||
| 317-W. | Generation of Monocyte-Derived Dendritic Cells (MD-DC) in Clinical GMP Conditions and their Ability to Activate CD4 and CD8 T Cells to HIV Antigens in Early HIV+ Individuals Receiving HAART M. Lejeune*1, F. García1, C. Gil1, J. Alcami2, J. Joseph1, J. Miró1, M. Plana1, J. M. Gatell2, and T. Gallart1 1Univ. of Barcelona and 2Inst. Carlos III, Madrid, Spain
| ||
| 318-W. | Augmentation of HIV-1-Specific Memory Subsets of T Lymphocytes and Decrease of Immune Activation in HIV-1+ Individuals Treated with a Therapeutic Vaccine plus Antiretrovirals: Impact on Viral Load E. Fernandez-Cruz*, J. Navarro, M. L. Abad, L. Díaz-Muñoz, C. Cantó, J. Carbone, S. Moreno, B. Clotet, J. Pérez Molina, J. M. Gatell, and M. Munoz-Fernandez for the Spanish 2102 Team Univ. Hosp. Gregorio Marañon, Madrid, Spain
|
